ADVITOS completes €20m financing round with the support of EIT Digital Accelerator

ADVITOS, an EIT Digital Accelerator supported company, has raised €20 million funding for its innovative muti-organ failure therapy solution. The financing round was led by Crédit Mutuel Equity, with a co-investment from the EIC Fund.

ADVITOS, a Munich-based company supported by the EIT Digital Accelerator, offers a highly technological solution for treating multiple organ failure – a common cause of death in intensive care units. The company has announced the completion of a €20 million financing round. The round was led by Crédit Mutuel Equity via its two subsidiaries, Crédit Mutuel Equity Germany and Crédit Mutuel Innovation. In addition, ADVITOS received funding from the European Union’s European Innovation Council (EIC) Fund as part of the EIC Accelerator Pilot blended finance programme.

The EIT Digital Accelerator has been supporting ADVITOS during this fundraising with dedicated coaching and targeted introductions to a selected pool of investors interested in their space, size and geography.

“This financing round is a major step in the further development of ADVITOS. It will enable us to grow much faster and seize the enormous market potential this unique and certified therapy has, not only in Europe, but globally.” – commented Dr. Bernhard Kreymann, Founder and CEO of ADVITOS.

“We have been lucky in taking advantage of the fundraising program offered by EIT Digital, and valued the expertise, persistence and outreach that the EIT Digital Accelerator team has offered to us. Providing this kind of highly competent hands-on fundraising support is a strongly needed and highly effective measure to secure and enable scaling of European deep tech innovations.” added Catherine Schreiber, co-founder of ADVITOS.